IR@PKUHSC  > 北京大学第二临床医学院
学科主题临床医学
ACHIEVING EARLY OPTIMAL RESPONSE IS ASSOCIATED WITH BETTER HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB OR NILOTINIB AS FRONTLINE THERAPY
Jiang, Q.1; Wang, H. B.2; Mo, X. D.1; Yu, L.1; Huang, X. J.1
刊名HAEMATOLOGICA
2015-06-01
suppl.1页:698-698
收录类别SCI ; ISTP
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Hematology
研究领域[WOS]Hematology
语种英语
WOS记录号WOS:000361204904302
引用统计
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/65767
专题北京大学第二临床医学院
北京大学精神卫生研究所_护理部
作者单位1.Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China
2.Peking Univ, Clin Res Inst, Beijing 100871, Peoples R China
推荐引用方式
GB/T 7714
Jiang, Q.,Wang, H. B.,Mo, X. D.,et al. ACHIEVING EARLY OPTIMAL RESPONSE IS ASSOCIATED WITH BETTER HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB OR NILOTINIB AS FRONTLINE THERAPY[J]. HAEMATOLOGICA,2015,suppl.1:698-698.
APA Jiang, Q.,Wang, H. B.,Mo, X. D.,Yu, L.,&Huang, X. J..(2015).ACHIEVING EARLY OPTIMAL RESPONSE IS ASSOCIATED WITH BETTER HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB OR NILOTINIB AS FRONTLINE THERAPY.HAEMATOLOGICA,suppl.1,698-698.
MLA Jiang, Q.,et al."ACHIEVING EARLY OPTIMAL RESPONSE IS ASSOCIATED WITH BETTER HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB OR NILOTINIB AS FRONTLINE THERAPY".HAEMATOLOGICA suppl.1(2015):698-698.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Jiang, Q.]的文章
[Wang, H. B.]的文章
[Mo, X. D.]的文章
百度学术
百度学术中相似的文章
[Jiang, Q.]的文章
[Wang, H. B.]的文章
[Mo, X. D.]的文章
必应学术
必应学术中相似的文章
[Jiang, Q.]的文章
[Wang, H. B.]的文章
[Mo, X. D.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。